PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1730428-3	1992	Therefore, a phase I study of intravenous melphalan utilizing GM-CSF (recombinant granulocyte-macrophage colony-stimulating factor) support was initiated.	Melphalan	42-51	colony stimulating factor 2	Homo sapiens	82-130	
1730428-2	1992	It was postulated that GM-CSF would permit the use of higher dose melphalan with only moderate myelosuppression easily manageable in an outpatient setting.	Melphalan	66-75	colony stimulating factor 2	Homo sapiens	23-29	
1730428-3	1992	Therefore, a phase I study of intravenous melphalan utilizing GM-CSF (recombinant granulocyte-macrophage colony-stimulating factor) support was initiated.	Melphalan	42-51	colony stimulating factor 2	Homo sapiens	62-68	
9053491-0	1997	Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.	Melphalan	150-159	colony stimulating factor 2	Homo sapiens	51-99	
1730428-8	1992	Utilizing 20 micrograms/kg/day GM-CSF, the maximum tolerated dose (MTD) of melphalan is 30 mg/m2 and, with 10 mg/kg/day GM-CSF, the maximum tolerated melphalan dose is only 20 mg/m2.	Melphalan	75-84	colony stimulating factor 2	Homo sapiens	31-37	
2200536-2	1990	In an attempt to stimulate earlier granulocyte recovery, recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was administered subcutaneously to 23 patients with refractory myeloma who had been treated with melphalan at a high dose of 100 mg/m2.	Melphalan	230-239	colony stimulating factor 2	Homo sapiens	75-123	
2200536-8	1990	These results support the usefulness of low-dose GM-CSF (0.25 mg/m2) in stimulating marrow recovery in selected patients with adequate marrow reserve treated with high-dose melphalan for refractory multiple myeloma.	Melphalan	173-182	colony stimulating factor 2	Homo sapiens	49-55	
1692472-0	1990	Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.	Melphalan	74-83	colony stimulating factor 2	Homo sapiens	0-48	
1692472-0	1990	Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.	Melphalan	74-83	colony stimulating factor 2	Homo sapiens	50-56